NASD · Healthcare · Health Information Services · USA
OptimizeRx Corp is a micro cap company (market value under $300 million) in the Health Information Services industry.
OptimizeRx is a digital healthcare technology company providing marketing solutions to life sciences brands, healthcare providers, and patients. The company offers platforms including its Dynamic Audience Activation Platform for targeting healthcare providers and Micro-Neighborhood Targeting for direct-to-consumer marketing, delivering messages through electronic health records, prescription platforms, and consumer channels.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the OptimizeRx Corp stock.
Slightly overvalued: intrinsic value $8.86 per share, market price $9.32, margin of safety -5.2% (as of 2026-10-30).
Discounting its cash flows at 10.1% (average of 3 methods) values the shares at $8.86; the price of $9.32 is 5% above that value, and 73% of that value comes from beyond year five.
Leak Score: 56/100 on 11 of 12 signals (Weak Signal).
14 more funds hold it; the full list is part of the paid plan.
All 41 Health Information Services stocks
OPRX is slightly overvalued (as of the 2026-10-30 close). Discounting its cash flows at 10.1% (average of 3 methods) values the shares at $8.86; the price of $9.32 is 5% above that value, and 73% of that value comes from beyond year five.
$8.86 per share (as of the 2026-10-30 close), against a market price of $9.32. That is a margin of safety of -5.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
56 out of 100, which we rate "Weak Signal", on 11 of 12 value investing signals.